Obesity is a common nutritional problem often associated with diabetes, insulin resistance, and fatty liver (excess fat deposition in liver). Leptin-deficient Lep ob / Lep ob mice develop obesity and those obesity-related syndromes. Increased lipogenesis in both liver and adipose tissue of these mice has been suggested. We have previously shown that the transcription factor sterol regulatory element-binding protein-1 (SREBP-1) plays a crucial role in the regulation of lipogenesis in vivo. To explore the possible involvement of SREBP-1 in the pathogenesis of obesity and its related syndromes, we generated mice deficient in both leptin and SREBP-1. In doubly mutant Lep ob/ob ؋ Srebp-1 ؊/؊ mice, fatty livers were markedly attenuated, but obesity and insulin resistance remained persistent. The mRNA levels of lipogenic enzymes such as fatty acid synthase were proportional to triglyceride accumulation in liver. In contrast, the mRNA abundance of SREBP-1 and lipogenic enzymes in the adipose tissue of Lep ob /Lep ob mice was profoundly decreased despite sustained fat, which could explain why the SREBP-1 disruption had little effect on obesity. In conclusion, SREBP-1 regulation of lipogenesis is highly involved in the development of fatty livers but does not seem to be a determinant of obesity in Lep ob /Lep ob mice.
It has been reported that lipogenesis in both liver and adipose tissue is greater in obese animals than in lean controls (5, 6) . The livers of Lep ob/ob mice have an increase in triglyceride content, probably due to the increased lipogenesis paralleled by elevated mRNA expression and enzymatic activity of several lipogenic enzymes such as fatty acid synthase and ATP citrate lyase (5, 6, 9) .
Sterol regulatory element-binding proteins (SREBPs) 1 are transcription factors that belong to the basic helix-loop-helixleucine zipper family and regulate enzymes responsible for the synthesis of cholesterol, fatty acids, and triglycerides (10, 11) . To date, three SREBP isoforms, SREBP-1a, -1c, and -2, have been identified and characterized. SREBP-1a and -1c are transcribed from the same gene, each by a distinct promoter, and the predominant SREBP-1 isoform in liver and adipose tissue is SREBP-1c. Whereas SREBP-2 is relatively selective in transcriptionally activating cholesterol biosynthetic genes, SREBP-1c has a greater role in regulating fatty acid synthesis than cholesterol synthesis (12) (13) (14) (15) . SREBP-1c was also identified as adipocyte determination and differentiation factor-1 expressed in adipocytes and regulated during determination and differentiation of cultured adipocyte cell lines (16) . Thus, the role of SREBP-1 in the regulation of lipogenesis has been established (15, (17) (18) (19) . Moreover, SREBP-1 now appears to be positioned as a general mediator in the transcriptional action of insulin (20 -22) .
Recently, it has been reported that both SREBP-1c mRNA and its active nuclear protein are increased in Lep ob/ob mouse livers (23) . It is pathophysiologically intriguing and of clinical relevance to evaluate the possible involvement of SREBP-1 in the development of obesity and its related syndromes, since SREBP-1 could be a potential therapeutic target in these pathological states. These considerations prompted us to investigate the effects of SREBP-1 deletion on the phenotype of Lep ob/ob mouse by targeted gene disruption.
EXPERIMENTAL PROCEDURES
Animals-Mice deficient in SREBP-1 prepared as previously described (24) were back-crossed six times into the C57BL/6J background and intercrossed with animals heterozygous at the leptin locus (Lep (24) . Genotypes at the SREBP-1 locus were determined by Southern blot analysis with BamHI digestion (24) . Genotypes at the leptin locus were determined by a PCR-based restricted fragment length polymorphism analysis; DNA fragments amplified from genomic DNA by PCR using two primers designed on exon 2 of the leptin gene, 5Ј-TTTGTCCAAGATGGACCAGACT-3Ј and 5Ј-CAGG-GAGCAGCTCTTGGA-3Ј, were digested with DdeI restriction endonuclease (New England Biolabs), which cleaves only Lep ob allele-derived products. The digested fragments were separated on a 2.5% NuSieve 3:1 agarose gel (BioWhittaker Molecular Applications, Rockland, ME). PCR protocol was 35 cycles of 94°C for 1 min, 60°C for 1 min, and 72°C for 1 min.
Mice were housed in a temperature-controlled environment with a 12-h light/dark cycle and free access to water and a standard chow diet (Oriental MF, Oriental Yeast, Tokyo, Japan) containing 60% carbohydrate, 13% fat, and 27% protein on a caloric basis. All experiments were performed with 12-week-old mice. For the Lep ob/ob ϫ Srebp-1 Ϫ/Ϫ experiment, mice were refed for 12 h following a 24-h fast prior to sacrifice in order to minimize the variation in dietary conditions. For the fasting and refeeding study, mice were fasted for 24 h or refed for 12 h after 24-h starvation. All animals were sacrificed in an early phase of the light cycle under anesthesia with diethyl ether.
Blood Chemistries and Liver Lipid Analyses-Enzymatic assay kits were used for the determination of cholesterol (Determiner TC; cholesterol oxidase method; Kyowa Medex, Tokyo, Japan), triglycerides (TG LH; lipoprotein lipase method; Wako Chemicals, Tokyo, Japan), and nonesterified fatty acids (nonesterified fatty acid C; acyl-CoA oxidase method; Wako Chemicals). Plasma glucose was measured by ANT-SENSE II (Bayer Medical, Tokyo, Japan) based on the immobilized glucose oxidase membrane/hydrogen peroxide electrode method. Plasma insulin was determined by the mouse insulin enzyme-linked immunosorbent assay kit (Wako Chemicals). The content of cholesterol and triglycerides in liver was measured as described previously (25) .
RNA Isolation and Northern Blotting-Total RNA from liver and epididymal fat pad was isolated with Trizol reagent (Invitrogen), and 10-g RNA samples equally pooled from six mice of each genotype were run on a 1% agarose gel containing formaldehyde and transferred to a nylon membrane. The cDNA probes used were cloned as previously described (15, 26) . The probes were labeled with [␣-32 P]dCTP using the Megaprime DNA labeling system kit (Amersham Biosciences). The membranes were hybridized with the radiolabeled probe in Rapid-hyb Buffer (Amersham Biosciences) at 65°C with the exception of TNF␣, for which ULTRAhyb hybridization buffer (Ambion) was used at 42°C. The membranes were washed in 0.1ϫ SSC, 0.1% SDS at 65°C. Blots were exposed to Eastman Kodak Co. XAR-5 film and the BAS imaging plate for the BAS2000 BIO IMAGING ANALYZER (Fuji Photo Film, Tokyo, Japan). The quantification results obtained with the BAS2000 system were normalized to the signal generated from 36B4 (acidic ribosomal phosphoprotein P0) mRNA. ϫ Srebp-1 Ϫ/Ϫ . Total RNA (10 g) pooled equally from six mice was subjected to Northern blotting, followed by hybridization with the indicated cDNA probes. FAS, fatty acid synthase; SCD, stearoyl-CoA desaturase; GPAT, glycerol-3-phosphate acyltransferase; ACL, ATP citrate lyase; S14, Spot 14; HMGCoAsyn, hydroxymethylglutaryl-CoA synthase; G6PD, glucose-6-phosphate dehydrogenase; PK, pyruvate kinase; GK, glucokinase. A cDNA probe for 36B4 (acidic ribosomal phosphoprotein P0) was used to confirm equal loading. *, the aberrant messenger RNA from the disrupted Srebp-1 allele that encodes a truncated protein that is null for transcriptional activity. The results of quantification by the BAS imaging plate are shown in Table II . We concluded from these findings that the absence of SREBP-1 had no effect on the obesity and insulin resistance of Lep ob/ob mice; however, it did ameliorate triglyceride accumulation in liver.
RESULTS

Effects of SREBP
Mechanisms Figs.  2-4 ) from the disrupted allele was previously reported to be inactive as a transcription factor (15, 24) . By Northern blot analysis, we were able to show that the mRNA levels of various lipogenic enzymes such as fatty acid synthase, stearoyl-CoA desaturase 1, glycerol-3-phosphate acyltransferase, ATP citrate lyase, and spot 14 were decreased by SREBP-1 deletion in Lep ob/ob mice livers. Meanwhile, mRNA levels for hydroxymethylglutaryl-CoA synthase, a key enzyme of cholesterol biosynthesis, and its controlling transcription factor, SREBP-2, were reciprocally increased in Lep ob/ob ϫ Srebp-1 Ϫ/Ϫ mice. These differences were confirmed to be statistically significant by another Northern blot analysis quantifying gene expression levels in individual animals. The expression levels of glucokinase and pyruvate kinase, major glycolytic enzymes, were not altered by SREBP-1 disruption.
Distinct Influence of SREBP-1 Absence on Lipogenesis in Adipose Tissue-While the adiposity of liver was significantly decreased in the Lep ob/ob ϫSrebp-1 Ϫ/Ϫ mice, adipose tissue mass was unchanged. To investigate the mechanism by which this occurs, we evaluated the mRNA levels of various lipogenic genes in the adipose tissue of mice from each group by Northern blot analysis (Fig. 3, Table III 
Effects of SREBP-1 Disruption on Markers for Insulin
Resistance-Several adipocyte-derived genes such as tumor necrosis factor ␣ (TNF␣) and peroxisome proliferator-activated receptor ␥ (PPAR␥) have been implicated to be related to insulin resistance in adipose tissue (27) , and their mRNA levels were also examined in our study. We demonstrated that the expression of PPAR␥, a nuclear receptor for thiazolidinedions, insulin-sensitizing drugs, was decreased, whereas TNF␣, which has been suggested to be a causal cytokine for insulin resistance, was increased in the adipose tissue of Lep ob/ob mice compared with wild type (Fig. 3 (17, 28) and leptin (29) that had been reported to be regulated by SREBP-1 were also independent of Srebp-1 genotype, which held true again in the Lep ϩ /Lep ϩ background (Fig. 4) . (30, 31) . The difference was more pronounced in our experiments that were performed in a refed state (Fig. 5) . It has been shown by enzymatic assay experiments that lipogenesis in Lep ob/ob mouse adipose tissue is elevated in the early dynamic phase until 7-8 weeks of age and thereafter suppressed in the late static phase when insulin resistance becomes evident (32, 33) . In contrast, hepatic lipogenesis in Lep ob/ob mice remains consistently higher than in wild-type animals. Therefore, lipogenesis is not likely to be important in the sustained hypertrophy of adipocytes in older Lep ob/ob mice. These results can be explained by the fact that adipose mass is related not only to de novo fatty acid synthesis but also to fatty acid intake mediated through lipoprotein lipase (34) . In our data, the expression of lipoprotein lipase was not affected by SREBP-1 absence, which could be another reason for sustained obesity in the doubly mutant mice. Adipocyte hypertrophy can be also influenced by lipolysis through the action of hormone-sensitive lipase (35) .
Defective Responses of Lep ob/ob Lipogenic Enzymes in Adi-
We conclude from these results that the inherent suppression of SREBP-1 in Lep ob/ob mouse adipose tissue was the primary cause of the ineffectiveness of SREBP-1 disruption on obesity. Another factor that might explain the phenotypic discrepancy between liver and adipose tissue in the Lep ob/ob ϫ Srebp-1 Ϫ/Ϫ mice is the different contribution of SREBP-1 to the regulation of lipogenesis in the two organs (15) ; the disruption of SREBP-1 strongly suppressed the refeeding responses of lipogenic enzymes in the liver, whereas their expression was less influenced by SREBP-1 levels in the adipose tissue. It is possible that there are other specific transcription factors that regulate lipogenesis in adipocytes and that SREBP-1 contribution is of minor importance in this tissue (15) .
We demonstrated that the adipose tissue of older Lep ob/ob mice could not respond fully to the refeeding manipulation, whereas the livers responded normally at least with respect to lipogenesis. Given that the refeeding response of lipogenesis highly depends upon insulin action, it could be said that hyperinsulinemia in Lep ob/ob mice could overcome insulin resistance to lipogenesis in the liver but could not in the adipose tissue. This is consistent with previous reports that the adipose tissue was more affected in an insulin-resistant state of Lep ob/ob mice than the liver where lipid synthesis remained sensitive to insulin stimulation throughout life (6) .
It has been reported that nonalcoholic fatty liver disease is associated with insulin resistance and hyperinsulinemia even in lean subjects with normal glucose tolerance (36) . Fatty liver disease and insulin resistance in these patients might represent an initial stage of the metabolic syndrome X (37, 38) . In this study, we were able to segregate fatty liver disease from insulin resistance syndromes by the disruption of SREBP-1, an indication that excess triglyceride accumulation in the liver is not a cause but rather the result of insulin resistance and hyperinsulinemia.
In summary, we demonstrated that the absence of SREBP-1 attenuated fatty livers but not obesity or insulin resistance in Lep ob/ob mice. It was revealed that SREBP-1 plays a crucial role in the regulation of lipogenic gene expression and triglyceride accumulation in the liver. The ineffectiveness of SREBP-1 disruption on obesity presumably resulted from the decreased expression of SREBP-1 in Lep ob/ob mouse adipose tissue. The data also suggested that lipogenesis is not a determinant of obesity in Lep ob/ob mice.
